Inhibikase Therapeutics, Inc. · NASDAQ:IKT
Ra Capital Management, L.P. reported a 15.90% stake in Inhibikase Therapeutics, Inc. (Schedule 13G)
Event Jul 10, 2026 · Filed Jul 17, 2026
Ra Capital Management, L.P. reported a 15.90% stake in Inhibikase Therapeutics, Inc., 25,000,000 shares, as a passive investor on Jul 10, 2026. Filed Jul 17, 2026 (Schedule 13G).
- Stake
- 15.90%
- Shares
- 25,000,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RA Capital Management, L.P. | 15.90% | 25,000,000 |
| Peter Kolchinsky | 15.90% | 25,000,000 |
| Rajeev Shah | 15.90% | 25,000,000 |
| RA Capital Healthcare Fund, L.P. | 15.90% | 25,000,000 |
Source
Related
- Inhibikase Therapeutics, Inc.
- Ra Capital Management, L.P.
- Inhibikase Therapeutics, Inc. shareholders
- Schedule 13G/A · Ra Capital Management, L.P. · Jul 31, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Nantahala Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Sands Capital Life Sciences Pulse Fund II, L.P. · Aug 13, 2026
- Form 4 · Berman Dennis N · Jul 31, 2026
- Form 4 · RA Capital Healthcare Fund LP · Jul 31, 2026